Genetic Epidemiology, Translational Neurogenomics, Psychiatric Genetics and Statistical Genetics Laboratories investigate the pattern of disease in families, particularly identical and non-identical twins, to assess the relative importance of genes and environment in a variety of important health problems.
QIMR Home Page
GenEpi Home Page
About GenEpi
Publications
Contacts
Research
Staff Index
Collaborators
Software Tools
Computing Resources
Studies
Search
GenEpi Intranet
PMID
42780237
TITLE
Unravelling the genetic basis of stuttering: GWAS meta-analysis highlights link with rare speech disorders.
ABSTRACT
BACKGROUND NlmCategory: UNASSIGNED
Developmental stuttering affects up to 11% of children globally, with around one-fifth developing a persistent lifelong stutter. Twin and family studies indicate a strong genetic contribution and comorbidity with other heritable traits. Despite efforts to investigate the common genetic architecture of stuttering, much of variation contributing to clinically ascertained stuttering, persistence and recovery remains uncharacterised.
METHODS NlmCategory: UNASSIGNED
Developmental stuttering affects up to 11% of children globally, with around one-fifth developing a persistent lifelong stutter. Twin and family studies indicate a strong genetic contribution and comorbidity with other heritable traits. Despite efforts to investigate the common genetic architecture of stuttering, much of variation contributing to clinically ascertained stuttering, persistence and recovery remains uncharacterised. We performed a genome-wide association study (GWAS) meta-analysis of stuttering across 18 cohorts (6,096 cases, 81,629 controls) of European ancestries, with secondary analyses of stuttering persistence and sex-stratified GWAS.
FINDINGS NlmCategory: UNASSIGNED
Developmental stuttering affects up to 11% of children globally, with around one-fifth developing a persistent lifelong stutter. Twin and family studies indicate a strong genetic contribution and comorbidity with other heritable traits. Despite efforts to investigate the common genetic architecture of stuttering, much of variation contributing to clinically ascertained stuttering, persistence and recovery remains uncharacterised. We performed a genome-wide association study (GWAS) meta-analysis of stuttering across 18 cohorts (6,096 cases, 81,629 controls) of European ancestries, with secondary analyses of stuttering persistence and sex-stratified GWAS. No variant reached genome-wide significance in the primary meta-analysis, but 24 loci showed suggestive association (p<1×10⁻⁵), with SNP-based heritability estimated at h²≈0·26. FLAMES-prioritised genes at suggestive loci overlapped with those previously implicated in childhood apraxia of speech, including , , , , and , with significant enrichment for apraxia-associated genes overall (p=1×10⁻⁴). Meta-analysis with an independent self-reported stuttering GWAS identified a genome-wide significant association at and gene-level convergence at and . A polygenic risk score derived from this independent GWAS was associated with stuttering susceptibility and severity within clinically ascertained cases. Partitioned heritability analysis pointed to enrichment in conserved regulatory regions, and integration with imaging data highlighted motor circuitry including decreased pallidum volume and cerebellar and white-matter microstructural differences.
INTERPRETATION NlmCategory: UNASSIGNED
Developmental stuttering affects up to 11% of children globally, with around one-fifth developing a persistent lifelong stutter. Twin and family studies indicate a strong genetic contribution and comorbidity with other heritable traits. Despite efforts to investigate the common genetic architecture of stuttering, much of variation contributing to clinically ascertained stuttering, persistence and recovery remains uncharacterised. We performed a genome-wide association study (GWAS) meta-analysis of stuttering across 18 cohorts (6,096 cases, 81,629 controls) of European ancestries, with secondary analyses of stuttering persistence and sex-stratified GWAS. No variant reached genome-wide significance in the primary meta-analysis, but 24 loci showed suggestive association (p<1×10⁻⁵), with SNP-based heritability estimated at h²≈0·26. FLAMES-prioritised genes at suggestive loci overlapped with those previously implicated in childhood apraxia of speech, including , , , , and , with significant enrichment for apraxia-associated genes overall (p=1×10⁻⁴). Meta-analysis with an independent self-reported stuttering GWAS identified a genome-wide significant association at and gene-level convergence at and . A polygenic risk score derived from this independent GWAS was associated with stuttering susceptibility and severity within clinically ascertained cases. Partitioned heritability analysis pointed to enrichment in conserved regulatory regions, and integration with imaging data highlighted motor circuitry including decreased pallidum volume and cerebellar and white-matter microstructural differences. Our findings support common variant associations in stuttering converging on genes implicated in speech and neurodevelopmental conditions, pointing to basal ganglia-cerebellar motor circuits as central to speech motor control.
FUNDING NlmCategory: UNASSIGNED
Developmental stuttering affects up to 11% of children globally, with around one-fifth developing a persistent lifelong stutter. Twin and family studies indicate a strong genetic contribution and comorbidity with other heritable traits. Despite efforts to investigate the common genetic architecture of stuttering, much of variation contributing to clinically ascertained stuttering, persistence and recovery remains uncharacterised. We performed a genome-wide association study (GWAS) meta-analysis of stuttering across 18 cohorts (6,096 cases, 81,629 controls) of European ancestries, with secondary analyses of stuttering persistence and sex-stratified GWAS. No variant reached genome-wide significance in the primary meta-analysis, but 24 loci showed suggestive association (p<1×10⁻⁵), with SNP-based heritability estimated at h²≈0·26. FLAMES-prioritised genes at suggestive loci overlapped with those previously implicated in childhood apraxia of speech, including , , , , and , with significant enrichment for apraxia-associated genes overall (p=1×10⁻⁴). Meta-analysis with an independent self-reported stuttering GWAS identified a genome-wide significant association at and gene-level convergence at and . A polygenic risk score derived from this independent GWAS was associated with stuttering susceptibility and severity within clinically ascertained cases. Partitioned heritability analysis pointed to enrichment in conserved regulatory regions, and integration with imaging data highlighted motor circuitry including decreased pallidum volume and cerebellar and white-matter microstructural differences. Our findings support common variant associations in stuttering converging on genes implicated in speech and neurodevelopmental conditions, pointing to basal ganglia-cerebellar motor circuits as central to speech motor control. Australian National Health and Medical Research Council.
RESEARCH IN CONTEXT NlmCategory: UNASSIGNED
Developmental stuttering affects up to 11% of children globally, with around one-fifth developing a persistent lifelong stutter. Twin and family studies indicate a strong genetic contribution and comorbidity with other heritable traits. Despite efforts to investigate the common genetic architecture of stuttering, much of variation contributing to clinically ascertained stuttering, persistence and recovery remains uncharacterised. We performed a genome-wide association study (GWAS) meta-analysis of stuttering across 18 cohorts (6,096 cases, 81,629 controls) of European ancestries, with secondary analyses of stuttering persistence and sex-stratified GWAS. No variant reached genome-wide significance in the primary meta-analysis, but 24 loci showed suggestive association (p<1×10⁻⁵), with SNP-based heritability estimated at h²≈0·26. FLAMES-prioritised genes at suggestive loci overlapped with those previously implicated in childhood apraxia of speech, including , , , , and , with significant enrichment for apraxia-associated genes overall (p=1×10⁻⁴). Meta-analysis with an independent self-reported stuttering GWAS identified a genome-wide significant association at and gene-level convergence at and . A polygenic risk score derived from this independent GWAS was associated with stuttering susceptibility and severity within clinically ascertained cases. Partitioned heritability analysis pointed to enrichment in conserved regulatory regions, and integration with imaging data highlighted motor circuitry including decreased pallidum volume and cerebellar and white-matter microstructural differences. Our findings support common variant associations in stuttering converging on genes implicated in speech and neurodevelopmental conditions, pointing to basal ganglia-cerebellar motor circuits as central to speech motor control. Australian National Health and Medical Research Council. We searched PubMed for genome-wide association studies (GWAS) of stuttering, using terms including "stuttering," "stammering," and "genome-wide association," for studies prior to July 2026, with no language restriction. Prior GWAS of stuttering are limited. The International Stuttering Project combined clinically ascertained and self-reported cases with population controls and identified one genome-wide significant locus near and 15 loci at suggestive significance. Another study investigating predicted stuttering within Vanderbilt's Electronic Health Records, identified one locus surpassing genome-wide significance near . A larger GWAS using self-reported stuttering status identified 57 genome-wide significant loci. Twin and family studies estimate stuttering heritability at 0·42-0·85, and rare variant studies have implicated genes including , , , , , and in familial persistent stuttering, but it remains unclear whether these genes are also relevant to common genetic variation in the general population. We conducted the largest GWAS meta-analysis of stuttering to combine clinically ascertained cases with population-based cohorts, comprising 18 cohorts, 6,096 cases, and 81,629 controls. Unlike prior studies based solely on self-report, many of our ascertained cases had detailed phenotyping including measures of persistence and quantitative severity, allowing us to examine genetic overlap between stuttering onset, persistence, and severity. We identified suggestive genetic loci that converge with genes previously implicated in a rare, severe motor speech disorder (childhood apraxia of speech), and found that combining our data with the independent, previous GWAS of self-reported stuttering identified a genome-wide significant association. We further used imaging genetics approaches to link genetic risk for stuttering to specific brain regions and circuits involved in motor control, and used evolutionary genomic analyses to show that stuttering-associated regions are enriched in ancient, conserved parts of the genome. Our findings suggest that common genetic variation contributing to stuttering converges on the same genes and brain circuits implicated in rare, severe speech disorders. This strengthens the case that stuttering, at least in part, shares a biological basis with other neurodevelopmental and speech-motor conditions, and points to the basal ganglia- cerebellar motor circuit as a promising target for future mechanistic research. For clinicians and people who stutter, these findings do not yet have direct treatment implications, but they lay groundwork for better understanding why stuttering persists in some individuals and not others, and highlight the value of collecting detailed speech and language phenotypes in future large-scale genetic studies.
DATE PUBLISHED
2026 Sep 16
HISTORY
PUBSTATUS PUBSTATUSDATE
medline 2026/09/24 12:50
pubmed 2026/09/24 12:49
entrez 2026/09/24 10:16
pmc-release 2026/09/22
AUTHORS
NAME COLLECTIVENAME LASTNAME FORENAME INITIALS AFFILIATION AFFILIATIONINFO
Jackson VE Jackson Victoria E VE
Shin JJ Shin Jenna J JJ
Horton S Horton Sarah S
Boyce JO Boyce Jessica O JO
Eising E Eising Else E
van Reyk O van Reyk Olivia O
Parker R Parker Richard R
Thompson-Lake DGY Thompson-Lake Daisy G Y DGY
Evans M Evans Meghan M
Beilby J Beilby Janet J
Below JE Below Jennifer E JE
Boomsma DI Boomsma Dorret I DI
Bridges E Bridges Elinor E
Corfield EC Corfield Elizabeth C EC
Franken MJ Franken Marie-Christine J MJ
Gordon SD Gordon Scott D SD
Havdahl A Havdahl Alexandra A
Koenraads SPC Koenraads Simone P C SPC
Kraft SJ Kraft Shelly Jo SJ
Luciano M Luciano Michelle M
Moen GH Moen Gunn-Helen GH
Mountford HS Mountford Hayley S HS
Musial A Musial Agnieszka A
Pennell CE Pennell Craig E CE
Polikowsky HG Polikowsky Hannah G HG
Pool R Pool René R
Rebattu VA Rebattu Valerie A VA
Rimfeld K Rimfeld Kaili K
Scartozzi AC Scartozzi Alyssa C AC
Pourcain BS Pourcain Beate St BS
Szilagyi IA Szilagyi Ingrid A IA
Valand SB Valand Stian B SB
Viljoen KZ Viljoen Kathryn Z KZ
Wang CA Wang Carol A CA
Whitehouse AJO Whitehouse Andrew J O AJO
Wren YE Wren Yvonne E YE
van Bergen E van Bergen Elsje E
Gillespie NA Gillespie Nathan A NA
Vogel AP Vogel Adam P AP
Scheffer IE Scheffer Ingrid E IE
Hildebrand MS Hildebrand Michael S MS
Sadleir LG Sadleir Lynette G LG
Liégeois F Liégeois Frédérique F
Reilly S Reilly Sheena S
Fisher SE Fisher Simon E SE
Martin NG Martin Nicholas G NG
Morgan AT Morgan Angela T AT
Bahlo M Bahlo Melanie M
INVESTIGATORS
JOURNAL
VOLUME:
ISSUE:
TITLE: medRxiv : the preprint server for health sciences
ISOABBREVIATION: medRxiv
YEAR: 2026
MONTH: Sep
DAY: 16
MEDLINEDATE:
SEASON:
CITEDMEDIUM: Internet
ISSN:
ISSNTYPE:
MEDLINE JOURNAL
MEDLINETA: medRxiv
COUNTRY: United States
ISSNLINKING:
NLMUNIQUEID: 101767986
PUBLICATION TYPE
PUBLICATIONTYPE TEXT
Journal Article
Preprint
COMMENTS AND CORRECTIONS
GRANTS
GENERAL NOTE
KEYWORDS
MESH HEADINGS
SUPPLEMENTARY MESH
GENE SYMBOLS
CHEMICALS
OTHER ID's